Illinois News Joint

MAY 16, 2023

Metrc stated, “Seamless data tracking in Metrc helps operators optimize inventory control, accurately report sales data, and improve cultivation management. To find more cannabis-friendly events in Illinois, visit here. To qualify and receive a medical patient card at a discounted rate, visit here.

Seed-To-Sale 67

Seed-To-Sale Supply Chain Data Compliance 67

Healer

NOVEMBER 15, 2023

Let’s start by taking a look at the new data and what it means. First, it’s important to point out that I usually wait until new data makes its way through the scientific peer-review process and is published in a journal before giving it much time and energy. During that time, 2,958 (1.9%) developed heart failure.

Data 126

Data Topical Research and Development Conditions 126

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. billion, servicing nearly 340,000 active patients. In 2019, the island’s economy grew by 2.1% in real terms to £4.97 to reach 3.2

Programs 100

Programs Data Events Collective 100

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

SpeedWeed

MARCH 13, 2021

Almost 25% of patients with Parkinson’s disease reported that they had used cannabis in the prior six months in a survey from the Parkinson’s Foundation. Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. More Than 1,000 PD Patients Surveyed.

Patients 52

Patients Treatment Therapy Sleep 52

Veriheal

MAY 30, 2023

A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. of patients experience pain after curative treatment, while 66.4% of patients with advanced or metastatic cancer suffer from pain. Interestingly, 72.5%

Medicine 98

Medicine Treatment Patients Data 98

CannaMD

MARCH 8, 2020

In January of 2020, the Journal of the American College of Cardiology published a review titled Marijuana Use in Patients With Cardiovascular Disease. Screening and testing for use of marijuana are encouraged in clinical settings, especially in the care of young patients presenting with cardiovascular disease. a heart attack).

Patients 79

Patients Marijuana Research and Development Clinical Trials 79

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

MedicalJane

DECEMBER 13, 2017

The state recently announced an expansion to its program that is beginning to open the door to improved patient access. Chronic pain, on its own, is already responsible for more than 7,500 new patients joining New York’s MMJ program. Problems Abound for Medical Professionals and Patients.

Programs 49

Programs Patients Chronic Pain Marijuana 49

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Illinois News Joint

MAY 12, 2023

Another paragraph added, “During hours of operation, dispense all cannabis from the restricted access area, a drive-through window of the restricted access area, or a pickup location in close proximity to the restricted access area. To find more cannabis-friendly events in Illinois, visit here.

Packaging 98

Packaging Agriculture Cannabis Cultivation 98

Cannabis Law Report

DECEMBER 7, 2021

While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events. Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. 1.69, 95% CI [1.20–2.36])

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. Data Highlights.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

JULY 22, 2021

A master distribution agreement has been signed with My Green Planet, a leading global agricultural supply group, giving Sporeo access to approximately 7,000 retailers across North America, Australia, and Europe. Levitee Labs aims to catalyze access to compounds and alternative medicines that enhances the wellbeing of society.

eCommerce 105

eCommerce Therapy Media Access 105

NORML

SEPTEMBER 20, 2019

But at the Vegas event, she brought good news: She announced that other universities would host her research, and she recently applied for a third-party cultivation license from the DEA, the only federal agency that can legally provide cannabis for clinical study in the US. Dr. Sisley: In the last study we just completed, each patient got 1.8

DEA 230

DEA Research and Development Clinical Trials Patients 230

Cannabis Law Report

AUGUST 27, 2021

This impressive group represents well-known leaders in the psychedelic and addiction fields and will help usher in a greater understanding of the science and data behind what we expect to be the most effective treatments for many mental health conditions ever available.”. About Delic Corp, Inc.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

JANUARY 23, 2022

Events like these afford us a glimpse into the future of research and medicine in this field. GVHD affects a significant portion of transplant patients, anywhere between 30% and 70% of patients depending on how closely the donor’s tissue matches with the patient. and 13.4%, respectively. Implications.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. COMP360 psilocybin therapy has now been given to 233 patients, exceeding 216 target. On track to report top-line data by end of 2021. million, or $0.79 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. Qualified patient. Thinking about getting your card? What about travel?

Law 126

Law Marijuana Patients Treatment 126

Project CBD

MAY 3, 2023

Dr. Goldstein has treated thousands of patients with medical cannabis. It’s noteworthy that much of this anecdotal data is supported by findings from preclinical research. I have used it in some of my patients with autism. There are pharmaceuticals for ADHD or behavioral issues, for example, which target this receptor.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Peninsula Alternative Health

JUNE 12, 2023

Patients will still be able to obtain medical cannabis from licensed dispensaries, and individuals aged 18 or older can register to participate in the program. The law includes provisions to ensure that registered patients continue to have access to their necessary medication, such as patient-only operating hours and product availability.

Legislation 52

Legislation Packaging Edibles Concentrates 52

Cannabis Law Report

AUGUST 24, 2021

Hoshi will use commercially reasonable efforts to grant Flora access to its European Union Good Manufacturing Practices (“EU-GMP”) auditors for the purposes of assisting Flora to obtain EU-GMP certification at its Cosechemos cultivation and extraction facility in Colombia. of the market. billion by 2028. from 2021 to reach €3.2

Events 105

Events Cultivation Access Business 105

Peninsula Alternative Health

JUNE 12, 2023

Patients will still be able to obtain medical cannabis from licensed dispensaries, and individuals aged 18 or older can register to participate in the program. The law includes provisions to ensure that registered patients continue to have access to their necessary medication, such as patient-only operating hours and product availability.

Legislation 52

Legislation Packaging Edibles Concentrates 52

Cannabis Law Report

MAY 29, 2022

The grand opening event and reception invited investors, stakeholders and the residents of Princeton to take a tour through the facilities. Businesses have been recently receiving approval from Health Canada to farm psychedelic mushrooms, make psilocybin and sell the compound to drug-makers, or to doctors to give to patients.

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

Cannabis Law Report

JULY 19, 2021

Founded in California , Papa’s Herb focuses on providing quality Cannabis products consistently, at accessible price points. 1 All sales figured sourced from BDSA Sales Data and the Company’s internal calculations. 2 All sales figures sourced from the May 2021 BDSA Sales Data.

Collective 105

Collective Data Cultivation Events 105

Illinois News Joint

FEBRUARY 7, 2023

The disparity and availability study begins 12 months of research that will measure accessibility, whether any discrimination exists, whether it impacts entry and participation, and suggest potential remedies for Illinois cannabis regulation. To learn about cannabis-friendly events in Illinois, visit here.

Agriculture 73

Agriculture Cannabis Policy Dispensary 73

Veriheal

SEPTEMBER 15, 2021

Qualitative and Quantitative Research: Qualitative research aims to use the social sciences to “collect, compare and interpret information”, while quantitative research aims to use “mathematical, statistical and computer-aided tools” to collect and measure the data. . a combination of the cabinet, the field, and/or the controlled environment.

Data 95

Data Collective Environment Cannabis 95

Veriheal

MAY 3, 2022

Kevin Potter taking responsibility for the integrity and accuracy of the data. a necessary question to address as medical marijuana becomes more accessible. The study also said that the participants could continue their usual treatments or psychiatric care but did not specify which conditions the patients had.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Cannabis Law Report

NOVEMBER 9, 2021

Delic has been focused on opening locations in secondary cities with considerable demand, in an effort to provide access to the most patients. Delic expects to drive considerable patients to KWC through its media platform and build on the existing national leadership position already in place. Transaction Summary.

Treatment 52

Treatment Therapy Media Access 52

Cannabis Law Report

NOVEMBER 24, 2019

Building the bridge between brands and the marketplace through testing and the importance of good data. These events, amongst other drivers, have shown the obvious need to regulate product safety in CBD and THC products in a holistic and standardized way.

Business 95

Business Data Wellness and Beauty Safety 95

Cannabis Law Report

SEPTEMBER 20, 2021

Delic expects to open 15 additional clinics across the country over the coming 18 months, further expanding access to millions who can benefit from psychedelic treatment for a variety of mental health conditions. Adding KWC will ensure our existing patients and many more in the future will receive the best medical treatment and care.

Treatment 52

Treatment Media Research and Development Patients 52

Cannabis Law Report

SEPTEMBER 23, 2021

The major concerns noted were adverse events following consumption (many from inadvertent intoxication), marketing to and use by minors, and the potential presence of harmful by-products and unsafe manufacturing practices. The FDA has received adverse event reports involving delta-8 THC-containing products. CDC Health Alert.

THC 52

THC Concentrates Pets DEA 52

Veriheal

OCTOBER 5, 2020

The program requires cannabis patients to have a licensed physician to certify that the individual would benefit from medical cannabis before they can register for it. The Hawaiian cannabis regulations also allow caregivers to take on the responsibility for managing the cannabis consumption and cultivation of the cannabis qualifying patient.

Edibles 52

Edibles Legalization Decriminalization Consumption 52

The Cannigma

DECEMBER 8, 2021

By sufficiently moving the needle on public opinion, NORML aims to legalize the responsible use of marijuana by adults, and subsequently ensure access to products that are safe, convenient, and affordable. To hear more of JM’s thoughts on the importance of small victories, how to build momentum, and patient rights, tune in today!

Access 81

Access Policy Patients Cannabis 81

Cannabis Law Report

DECEMBER 21, 2021

The rapid increase in the volume of enterprise data and growing automation of business processes across several end-use industries such as retail, manufacturing, healthcare, and transportation are expected to drive the demand for business software and services over the forecast period. billion in 2020 (Grandview Research). from 2021 to 2028.

Research and Development 52

Research and Development Supply Chain Data Business 52

Cannabis Law Report

JANUARY 13, 2020

We are proud of the positive impact this medicine has already had on thousands of patients and believe that this past year provides a compelling foundation for continued success in 2020,” said Justin Gover, GW’s Chief Executive Officer. “Our fourth quarter and full year results for 2019 reflect an exceptional launch year for Epidiolex.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66